조영진

All filings by 조영진 on record concern 삼성바이오로직스. The record holds 2 filings, for trades running from 3 April 2024 to 6 November 2025.

Both buying and selling appear: 1 purchase, against 1 sale. No amount is published for 2 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2025, the count stands at no purchases and 1 sale.

The latest filing, published on 6 November 2025, reports an open-market sale in 삼성바이오로직스. The most recent open-market purchase was published on 5 April 2024, 926 days ago. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.